Aardvark Therapeutics, Inc (AARD)
NGS · Common · CUSIP 002942100
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for AARD and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
002942100
IPO
2/13/2025 · $16.00/share
Business: iAardvark Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways to alleviate hunger for the treatment of metabolic diseases.

Company Contact

CEO
Tien-Li Lee
CFO
Nelson Sun
Headquarters
4370 La Jolla Village Drive, Suite 1050, San Diego, CA 92122
Phone
858-225-7696
Investor Relations
Carolyn Hawley. Inizio Evoke Comms · 619-849-5382 · InvestorRelations@aardvarktherapeutics.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »